Titre : | Gamma-hydroxybutyric acid (GHB) withdrawal: a case report (2007) |
Titre traduit : | (Etat de manque concernant le GHB : étude de cas) |
Auteurs : | W. R. BENNETT ; L. G. WILSON ; P. P. ROY-BYRNE |
Type de document : | Article : Périodique |
Dans : | Journal of Psychoactive Drugs (Vol.39 n°3, 2007) |
Article en page(s) : | 293-296 |
Note générale : |
Journal of Psychoactive Drugs, 2007, 39, (3), 293-296 |
Langues: | Anglais |
Discipline : | TRA (Traitement et prise en charge / Treatment and care) |
Mots-clés : |
Thésaurus mots-clés GHB ; SYNDROME DE SEVRAGE ; BENZODIAZEPINES ; ETUDE DE CAS |
Résumé : |
ENGLISH : GHB is an increasingly popular drug of abuse that can be associated in select cases with growing dependence and a severe withdrawal syndrome. While benzodiazepines are recommended for treatment of the withdrawal syndrome, some cases have been described as benzodiazepine-resistant. The authors describe treatment of such a case, which was unsuccessfully treated initially with benzodiazepines, then successfully treated with adjuvant atypical neuroleptics, and offer a possible neurochemical explanation for why such agents may be theoretically more effective than benzodiazepines in treating GHB withdrawal. (Author' s abstract) |
Domaine : | Drogues illicites / Illicit drugs |
Refs biblio. : | 14 |
Affiliation : |
Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine at Harborview Medical Center, Seattle, WA 98104, USA. mbennett@u.washington.edu Etats-Unis. United States. |
Numéro Toxibase : | 1302289 |
Centre Emetteur : | 13 OFDT |
Cote : | Abonnement |
Accueil